R. S. Kalinin

Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished Survival

R. S. Kalinin, V. M. Ukrainskaya, Anastasia M. Moysenovich et al. · Frontiers in Molecular Biosciences · 2021 · 42 citations · Full text

Medicine, Immunology, Oncology +17

Switchable targeting of solid tumors by BsCAR T cells

R. S. Kalinin, Victoria O. Shipunova, Ding Zhang et al. · Proceedings of the National Academy of Sciences · 2022 · 29 citations · Full text

Medicine, Biotechnology, Oncology +16

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

Oleg V. Markov, Ivan V. Chernikov, Daniil V. Gladkikh et al. · Science Advances · 2018 · 26 citations · Full text

Medicine, Immunology, Oncology +14

Control of the antitumour activity and specificity of CAR T cells via organic adapters covalently tethering the CAR to tumour cells

Jia Xie, Qiaoqiao Zhu, Zuyuan Shen et al. · Nature Biomedical Engineering · 2023 · 25 citations

Life Sciences, Immunology, Oncology +15

Molecular Approaches to Safe and Controlled Engineered T-cell Therapy

R. S. Kalinin, Alexey Petukhov, Michael Maschan et al. · Acta Naturae · 2018 · 11 citations · Full text

Life Sciences, Biotechnology, Immunology +17